Drugs / DS-1150b
last change Oct 2013 re-read 3 minutes ago

DS-1150b

Developed for
type 2 diabetes mellitus
Investigated by
Daiichi Sankyo

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02004678 Sep 2013 type 2 diabetes mellitus Daiichi Sankyo Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DS-1150b ClinicalTrials.gov intervention name — accepted as the source's own label NCT02004678 ↗
Route Oral “single oral dose of DS-1150b” NCT02004678 ↗